Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Episurf Medical ABEPSFF 42 Equity-to-Asset is 0.77 as of Mar. 2026, which is 13% below its 10-year median of 0.88. GuruFocus rates EPSFF with a GF Score™ of 42/100 and a GF Value™ of $0.12. The stock has 7 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Episurf Medical AB ranks better than 70.39% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Episurf Medical AB's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $59.50 Mil. Episurf Medical AB's Total Assets for the quarter that ended in Mar. 2026 was $77.49 Mil.
Therefore, Episurf Medical AB's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.77.
The historical rank and industry rank for Episurf Medical AB's Equity-to-Asset or its related term are showing as below:
EPSFF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.63 Med: 0.88 Max: 0.94
Current: 0.77
During the past 13 years, the highest Equity to Asset Ratio of Episurf Medical AB was 0.94. The lowest was 0.63. And the median was 0.88.
EPSFF's Equity-to-Asset is ranked better than 70.39% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs EPSFF: 0.77
Episurf Medical AB (OTCPK:EPSFF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Episurf Medical AB Equity-to-Asset Related Terms
Episurf Medical AB Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Episurf Medical AB's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPSFF vs ABT, SYK, MDT: Equity-to-Asset Comparison
For the Medical Devices subindustry, Episurf Medical AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Episurf Medical AB Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Episurf Medical AB's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Episurf Medical AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Episurf Medical AB (EPSFF) has a Equity-to-Asset of 0.77 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Episurf Medical AB and its competitors. This is 13% below median its historical median of 0.88. Over the past decade, Episurf Medical AB's Equity-to-Asset has ranged from 0.63 to 0.94. According to the industry distribution chart, Episurf Medical AB ranks #252 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 29.6%.
Is Episurf Medical AB's Equity-to-Asset too high?
Episurf Medical AB's current Equity-to-Asset of 0.77 is 13% below median its 10-year median of 0.88. Over the past 10 years, this metric has ranged from a low of 0.63 to a high of 0.94. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Episurf Medical AB's value of 0.77 is 20.3% above this industry median. Based on the distribution chart, Episurf Medical AB ranks #252 out of 851 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Episurf Medical AB has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Episurf Medical AB's Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Episurf Medical AB ranks #252 out of 851 companies for Equity-to-Asset. This puts Episurf Medical AB in the upper half of its industry. The industry median Equity-to-Asset is 0.64. Episurf Medical AB's value of 0.77 is 20.3% above this benchmark. Historically, Episurf Medical AB's own Equity-to-Asset has ranged from 0.63 to 0.94 over the past decade. While the company's 10-year median is 0.88 vs. the industry median of 0.64, Episurf Medical AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Episurf Medical AB's current Equity-to-Asset of 0.77 is 20.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Episurf Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Episurf Medical AB's current Equity-to-Asset is 0.77, which is 13% below median its own 10-year median of 0.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Episurf Medical AB stock overvalued right now?
Episurf Medical AB (EPSFF) has a current Equity-to-Asset of 0.77. The stock's GF Value™ is $0.12, compared to a current price of $0.18 — trading 51.6% above its estimated fair value. The current Equity-to-Asset is 0.77, which is 13% below median its 10-year median of 0.88 and 20.3% above the Medical Devices & Instruments industry median of 0.64. Episurf Medical AB's overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Episurf Medical AB (EPSFF), the current Equity-to-Asset is 0.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Episurf Medical AB (EPSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Episurf Medical AB stock appears to be overvalued.
The current stock price of $0.18 is trading 51.6% above its estimated GF Value™ of $0.12.
Key valuation signals for EPSFF:
Equity-to-Asset: 0.77 (13% below median its 10-year median of 0.88)
GF Value™: $0.12 vs. price of $0.18 (51.6% above fair value)
Industry Position: 20.3% above the Medical Devices & Instruments median (#252 of 851)
No single metric tells the full story. See the EPSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint. The company is forming a new strategic business segment through the acquisition of real estate assets.
42GF Score
Get the complete analysis for EPSFF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EPSFF has been successfully added to your 
